Hyundai ADM Bio Statistics

Total Valuation

Hyundai ADM Bio has a market cap or net worth of KRW 55.59 billion. The enterprise value is 53.62 billion.

Market Cap	55.59B
Enterprise Value	53.62B

Important Dates

The next estimated earnings date is Monday, March 17, 2025.

Earnings Date	Mar 17, 2025
Ex-Dividend Date	n/a

Share Statistics

Hyundai ADM Bio has 42.31 million shares outstanding. The number of shares has increased by 0.00% in one year.

Current Share Class	n/a
Shares Outstanding	42.31M
Shares Change (YoY)	+0.00%
Shares Change (QoQ)	+19.42%
Owned by Insiders (%)	1.75%
Owned by Institutions (%)	n/a
Float	27.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	5.37
PB Ratio	5.77
P/TBV Ratio	6.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-2.88
EV / Sales	5.18
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-3.65

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.91.

Current Ratio	0.70
Quick Ratio	0.54
Debt / Equity	0.91
Debt / EBITDA	n/a
Debt / FCF	-0.56
Interest Coverage	-18.21

Financial Efficiency

Return on equity (ROE) is -87.19% and return on invested capital (ROIC) is -38.16%.

Return on Equity (ROE)	-87.19%
Return on Assets (ROA)	-26.68%
Return on Capital (ROIC)	-38.16%
Revenue Per Employee	64.69M
Profits Per Employee	-116.45M
Employee Count	160
Asset Turnover	0.27
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +38.10% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+38.10%
50-Day Moving Average	1,677.51
200-Day Moving Average	1,605.98
Relative Strength Index (RSI)	30.07
Average Volume (20 Days)	170,836

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Hyundai ADM Bio had revenue of KRW 10.35 billion and -18.63 billion in losses. Loss per share was -440.42.

Revenue	10.35B
Gross Profit	129.70M
Operating Income	-16.21B
Pretax Income	-19.25B
Net Income	-18.63B
EBITDA	-14.55B
EBIT	-16.21B
Loss Per Share	-440.42

Full Income Statement

Balance Sheet

The company has 9.61 billion in cash and 8.22 billion in debt, giving a net cash position of 1.39 billion or 32.88 per share.

Cash & Cash Equivalents	9.61B
Total Debt	8.22B
Net Cash	1.39B
Net Cash Per Share	32.88
Equity (Book Value)	9.05B
Book Value Per Share	227.64
Working Capital	-5.88B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -14.61 billion and capital expenditures -96.18 million, giving a free cash flow of -14.70 billion.

Operating Cash Flow	-14.61B
Capital Expenditures	-96.18M
Free Cash Flow	-14.70B
FCF Per Share	-347.52

Full Cash Flow Statement

Margins

Gross margin is 1.25%, with operating and profit margins of -156.60% and -180.02%.

Gross Margin	1.25%
Operating Margin	-156.60%
Pretax Margin	-186.03%
Profit Margin	-180.02%
EBITDA Margin	-140.60%
EBIT Margin	-156.60%
FCF Margin	n/a

Dividends & Yields

Hyundai ADM Bio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.00%
Shareholder Yield	-0.00%
Earnings Yield	-33.52%
FCF Yield	-26.45%

Stock Splits

The last stock split was on November 27, 2024. It was a forward split with a ratio of 2.

Last Split Date	Nov 27, 2024
Split Type	Forward
Split Ratio	2

Scores

Hyundai ADM Bio has an Altman Z-Score of -0.38. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.38
Piotroski F-Score	n/a